ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

Medical Oncology Fosters Long Term Relationships

May 5, 1989

Clara Bloomfield To Receive ASCO’s Karnofsky Award. V. Craig Jordan Named Lombardi Scientific Director

April 17, 2009

Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense

June 23, 1989

High Risk Youth Targeted In Concept Ok’d By Advisors

February 8, 1991

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994